Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

11.35

+0.05 (0.44%)

At close: Mar 9, 2026, 4:00 PM EDT

11.35

0.00 (0.00%)

After-hours: Mar 9, 2026, 4:10 PM EDT

Keros Therapeutics Market Cap

Keros Therapeutics has a market cap or net worth of $223.79 million as of March 9, 2026. Its market cap has decreased by -49.91% in one year.

Market Cap

223.79M

Enterprise Value

-46.74M

1-Year Change

-49.91%

Ranking

#3764

Market Cap Chart

Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $223.79M, a decrease of -41.92%. That is a compound annual growth rate of -8.78%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	222.81M	-64.08%
Dec 31, 2025	620.29M	-3.27%
Dec 31, 2024	641.23M	-46.17%
Dec 29, 2023	1.19B	-9.94%
Dec 30, 2022	1.32B	-3.39%
Dec 31, 2021	1.37B	-16.27%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Canton Strategic Holdings	230.80M
Sol-Gel Technologies	227.45M
Achieve Life Sciences	227.31M
Alector	220.73M
Eledon Pharmaceuticals	220.60M
MediWound	218.50M
Camp4 Therapeutics	217.90M
Voyager Therapeutics	216.84M

Market Cap Rankings